POU2F3 (POU class 2 homeobox 3)

2007-02-01  

Identity

HGNC
LOCATION
11q23.3
LOCUSID
ALIAS
Epoc-1,OCT-11,OCT11,OTF-11,PLA-1,PLA1,Skn-1a
FUSION GENES

Other Information

Locus ID:

NCBI: 25833
MIM: 607394
HGNC: 19864
Ensembl: ENSG00000137709

Variants:

dbSNP: 25833
ClinVar: 25833
TCGA: ENSG00000137709
COSMIC: POU2F3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000137709ENST00000260264Q9UKI9
ENSG00000137709ENST00000532663H0YLC5
ENSG00000137709ENST00000533620E9PIN6
ENSG00000137709ENST00000543440Q9UKI9

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Herpes simplex infectionKEGGko05168
Herpes simplex infectionKEGGhsa05168

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
379042772024POU2F3-Expressing Small Cell Lung Carcinoma and Large Cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.1
379042772024POU2F3-Expressing Small Cell Lung Carcinoma and Large Cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.1
367165352023The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients.0
368155402023An integrated multiomics analysis of rectal cancer patients identified POU2F3 as a putative druggable target and entinostat as a cytotoxic enhancer of 5-fluorouracil.0
367165352023The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients.0
368155402023An integrated multiomics analysis of rectal cancer patients identified POU2F3 as a putative druggable target and entinostat as a cytotoxic enhancer of 5-fluorouracil.0
349886572022POU2F3 beyond thymic carcinomas: expression across the spectrum of thymomas hints to medullary differentiation in type A thymoma.13
355769712022OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage.23
357602872022POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.14
361979782022POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity.18
349886572022POU2F3 beyond thymic carcinomas: expression across the spectrum of thymomas hints to medullary differentiation in type A thymoma.13
355769712022OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage.23
357602872022POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.14
361979782022POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity.18
330113882020SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization.149

Citation

Dessen P

POU2F3 (POU class 2 homeobox 3)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/43760